News
The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...
Regeneron Pharmaceuticals ( NASDAQ: REGN) said on Thursday that the U.S. FDA will be reviewing the supplemental biologics license application ( (sBLA)) for Eylea HD injection, 8 mg, to treat macular ...
5hon MSN
With the help of her grandchildren, the mayoress walked around town wearing goggles mimicking diabetic retinopathy; a ...
The FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) injection 8mg for priority review.
BY CASSIUS LAMAI The Chairman of Etsako Central Local Government Area, Hon. Cephas Yakubu, in partnership with the Edo State government has flagged off a three-day free eye care initiative in ...
A WOMAN who went on Mounjaro in a bid to lose weight has issued an urgent warning to anyone considering the fat jab. Lucinda explained that the weight “piled on” during the Covid-19 ...
Medical laboratories have proven to be of great advantage to the healthcare system, offering various benefits in the test, diagnosis, and treatment stages ...
The Ohio State Medical Association has launched "Your Care is at Our Core" campaign in partnership with the AMA to advocate ...
The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion, and for ...
A team of researchers has identified a promising new approach that may one day help to restore vision in people affected by macular degeneration and other retinal disorders.
More than 25 Doheny Scientists and Clinician-Scientists to Present Posters, Papers and Mini symposia at Leading Eye Research Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results